Regeneron Pharmaceuticals

Photo
10.08.2021 • News

Regeneron Invests $1.8 Billion in Tarrytown

US biotech Regeneron is planning to invest roughly $1.8 billion over six years to expand its research, preclinical manufacturing and support facilities at its Westchester County campus in Tarrytown, New York.

Top-Feature

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Sanofi-Aventis Deutschland